Home  »  Equities Feed   »  5 Best Stocks under $1 To Buy Right Now...

5 Best Stocks under $1 To Buy Right Now

Penny stocks are a highly volatile class of investments that carry a lot of risks, so finding the best penny stocks to buy isn’t an easy task at all. The risk associated with penny stocks is often higher than that associated with mid-capitalization or large caps. The short-term trading market can still be profitable if you want to make money right now. Day traders and swing traders are some of the traders who make profitable short-term gains from trading penny stocks on a day-to-day basis.

It should be noted that these very cheap penny stocks have several qualitative features that make them a good buy, unlike the very cheap cryptocurrencies that have a very low price but are often virtually worthless.

Top 5 Cheap Stocks to Own Right Now

While finding safe stocks with the potential for monster gains isn't always easy, we've found a few that could pay out well. In fact, within our report, "Top 5 Cheap Stock to Own Right Now", we have identified five stocks we believe could appreciate the most even if you just have $1,000 to invest.

Sign up here to get your free report now. .

Sponsored

Normally, penny stocks trade at a price under $5 per share, but in this article, Stocks Telegraph is providing you with a list of the best penny stocks under $1.

Stocks under $1

Dave Inc. (DAVE)

Dave Inc. (DAVE) stock gained 16.59% to close Wednesday’s session at $0.73. The stock volume remained 123.36 million shares, which was higher than the average daily volume of 4.93 million shares within the past 50 days. DAVE shares have fallen by -92.61% over the last 12 months, and they have moved up by 6.57% in the past week. Over the past three months, the stock has lost -82.78%, while over the past six months, it has shed -91.96%. Further, the company has a current market of $303.99 million and its outstanding shares stood at 371.99 million.

According to a U.S. Securities and Exchange Commission filing, Vanguard Extended Market Index Fu has added its position in Dave Inc. (DAVE) to 2,249,990 shares, mirroring a recent increase of 0.45%. Vanguard Extended Market Index Fu added 10086.0 shares of Dave Inc. common stock bringing its total worth to about $1.55 million at the end of recent close, SEC documents show. Vanguard Extended Market Index Fu isn’t the only investment manager who changed stakes and is followed by Fidelity Extended Market Index Fu, which sold off 0.0 shares to end up with 873,033 shares worth $0.6 million. Schwab US Small Cap ETF raise its holdings by 0.05% in the company over the course of the most recent quarter. It now holds a 0.21% position in Dave Inc. thanks to 0.66 million shares amounting to $0.46 million.

Zomedica Corp. (ZOM)

The stock of Zomedica Corp. (ZOM) gained 5.20% to complete the last trading session at $0.26. The price range of the company’s shares was between $0.25 and $0.27. It traded 11.23 million shares, which was below its daily average of 18.92 million shares over 100 days. ZOM’s shares have dropped by -1.50% in the last five days, while they have added 4.37% in the last month. Further, it is currently trading at a price-to-book ratio of 0.97.

Looking at the overall sentiment about this stock we find that the community has adopted a bullish outlook, a sentiment shared by analysts offering their price forecasts for the stock for the next 12 months. The analysts estimate the stock will hit a 12-month high of $1.20, while a downturn for the stock is likely to see it drop to a low of $1.20. When we calculate the distance from the median price, we find that the stock will move 78.33% from its price at the previous close to touch the estimated average price. An upside towards the 12-month high will see the stock climb 78.33%, while a decline to the 12-month low will see the stock lose 78.33 of its current value.

Allena Pharmaceuticals Inc. (ALNA)

Allena Pharmaceuticals Inc. (ALNA) stock closed the last session at $0.12, decreasing 0.00% or $0.0. Shares of the company fluctuated between $0.1125 and $0.13 throughout the day. The number of shares exchanged was 24.01 million, less than the company’s 50-day daily volume of 29.76 million and higher than its Year-to-date volume of 14.39 million. In the past 12 months, the company’s stock has advanced by -86.87%, and in the last week, the stock has moved down by -17.86%. For the last six months, the stock has lost a total of -68.92%, and over the last three months, the stock has decreased by -36.99%. The stock has returned -80.59% so far this year.

BRENNER LOUIS MD, President, and CEO, of Allena Pharmaceuticals Inc. (ALNA), sold 40,328 shares of Allena Pharmaceuticals Inc. stock in an exchange that took place on Nov 15. The shares were sold at an average price of 0.81 each, amounting to a total Sale worth $32,666. As of the close of the Sale, President and CEO now directly holds 288,576 shares of the organization’s stock, which is now worth about $34629.11. The deal was disclosed in a Securities & Exchange Commission legal filing, which can be publicly viewed on the SEC website.

Vascular Biogenics Ltd. (VBLT)

Vascular Biogenics Ltd. (VBLT) stock added 10.23% to finish the last trading session at $0.25. The stock recorded a trading volume of 19.92 million shares, which is below the average daily trading volume published for the last 50 days of 1.95 million shares. The shares of Vascular Biogenics Ltd. have advanced by -40.94% in the last five days; however, they have lost -84.11% over the last month. The stock price has shed -84.11% over the last three months and has lost -88.22 percent so far this year. Additionally, it has a price-to-sales ratio that stands at 28.80.

Vascular Biogenics Ltd. (VBLT) has a 20-day trading average of $1.4193 and the current price is -90.12% off the 52-week high compared with a 14.82% distance from its 52-week low. The 50-day simple moving average of the closing price is $1.4938, and its 200-day simple moving average is $1.7047. If we look at the stock’s price movements over the week, volatility stands at 20.95%, which decreases to 11.27% over 1 month. It is also key to look at other market indicators of price movement for the stock, where we see that the relative strength index (RSI) is at 22.20 to suggest the stock is oversold.

Camber Energy Inc. (CEI)

On Wednesday, shares in Camber Energy Inc. (CEI) rise 0.11% to close the day at $0.38. The volume of shares traded was 17.35 million, which is lower than the average volume over the last three months of 22.46 million. During the trading session, the stock oscillated between $0.38 and $0.39. The company had an earnings per share ratio of -0.67. CEI’s stock has lost -9.64% of its value in the previous five sessions and -12.15% over the past one month but has lost -55.25% on a year-to-date basis. The stock’s 50-day moving average of $0.5091 is above the 200-day moving average of $0.8243. Moreover, the stock is currently trading at an RSI of 37.87.

Volatility is just a proportion of the anticipated day-by-day value extend—the range where an informal investor works. Greater instability implies a more noteworthy benefit or misfortune. After an ongoing check, Camber Energy Inc. (AMEX: CEI) stock is found to be 5.48% volatile for the week, while 6.44% volatility is recorded for the month. The outstanding shares have been calculated at 309.99M. Based on a recent bid, its distance from 20 days simple moving average is -2.71%, and its distance from 50 days simple moving average is -26.15% while it has -54.22% from the 200 days simple moving average.

Leave a Comment

Your email address will not be published.

[class^="wpforms-"]
[class^="wpforms-"]
[class^="wpforms-"]
[class^="wpforms-"]
[class^="wpforms-"]
[class^="wpforms-"]
[class^="wpforms-"]
[class^="wpforms-"]